151 related articles for article (PubMed ID: 34210495)
1. Germline Predisposition to Prostate Cancer in Diverse Populations.
Bree KK; Hensley PJ; Pettaway CA
Urol Clin North Am; 2021 Aug; 48(3):411-423. PubMed ID: 34210495
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing for hereditary prostate cancer: Current status and limitations.
Zhen JT; Syed J; Nguyen KA; Leapman MS; Agarwal N; Brierley K; Llor X; Hofstatter E; Shuch B
Cancer; 2018 Aug; 124(15):3105-3117. PubMed ID: 29669169
[TBL] [Abstract][Full Text] [Related]
3. Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Wang X; Waldman L; Silberman Y; Wang M; Tackey C; Hanna L; Vesprini D; Emmenegger U; Eisen A; Smoragiewicz M
Clin Genitourin Cancer; 2024 Jun; 22(3):102052. PubMed ID: 38461085
[TBL] [Abstract][Full Text] [Related]
4. Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
Paulo P; Maia S; Pinto C; Pinto P; Monteiro A; Peixoto A; Teixeira MR
PLoS Genet; 2018 Apr; 14(4):e1007355. PubMed ID: 29659569
[TBL] [Abstract][Full Text] [Related]
5. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
[TBL] [Abstract][Full Text] [Related]
6. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
7. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
Ndugga-Kabuye MK; Issaka RB
Fam Cancer; 2019 Oct; 18(4):465-469. PubMed ID: 31531760
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Prostate Cancer: Effects of Genetic Testing on Care.
Connors LM
Clin J Oncol Nurs; 2019 Feb; 23(1):32-35. PubMed ID: 30681994
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Germline Variations and Implications for Screening and Treatment.
Dias A; Kote-Jarai Z; Mikropoulos C; Eeles R
Cold Spring Harb Perspect Med; 2018 Sep; 8(9):. PubMed ID: 29101112
[TBL] [Abstract][Full Text] [Related]
10. Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
Sessine MS; Das S; Park B; Salami SS; Kaffenberger SD; Kasputis A; Solorzano M; Luke M; Vince RA; Kaye DR; Borza T; Stoffel EM; Cobain E; Merajver SD; Jacobs MF; Milliron KJ; Caba L; van Neste L; Mondul AM; Morgan TM
Urology; 2021 Oct; 156():96-103. PubMed ID: 34280438
[TBL] [Abstract][Full Text] [Related]
11. Germ-line mutations in mismatch repair genes associated with prostate cancer.
Grindedal EM; Møller P; Eeles R; Stormorken AT; Bowitz-Lothe IM; Landrø SM; Clark N; Kvåle R; Shanley S; Maehle L
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2460-7. PubMed ID: 19723918
[TBL] [Abstract][Full Text] [Related]
12. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
13. African American and Asian males: what do we know about germline predisposition to prostate cancer.
Pettaway CA
Can J Urol; 2019 Oct; 26(5 Suppl 2):27-28. PubMed ID: 31629423
[TBL] [Abstract][Full Text] [Related]
14. Predicted Chemotherapy Benefit for Breast Cancer Patients With Germline Pathogenic Variants in Cancer Susceptibility Genes.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Katz SJ
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426465
[TBL] [Abstract][Full Text] [Related]
15. New insights on familial colorectal cancer type X syndrome.
Garcia FAO; de Andrade ES; de Campos Reis Galvão H; da Silva Sábato C; Campacci N; de Paula AE; Evangelista AF; Santana IVV; Melendez ME; Reis RM; Palmero EI
Sci Rep; 2022 Feb; 12(1):2846. PubMed ID: 35181726
[TBL] [Abstract][Full Text] [Related]
16. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer.
Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY
BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins.
Jaballah-Gabteni A; Tounsi H; Kabbage M; Hamdi Y; Elouej S; Ben Ayed I; Medhioub M; Mahmoudi M; Dallali H; Yaiche H; Ben Jemii N; Maaloul A; Mezghani N; Abdelhak S; Hamzaoui L; Azzouz M; Boubaker S
J Transl Med; 2019 Jun; 17(1):212. PubMed ID: 31248416
[TBL] [Abstract][Full Text] [Related]
18. Hereditary prostate cancer - Primetime for genetic testing?
Heidegger I; Tsaur I; Borgmann H; Surcel C; Kretschmer A; Mathieu R; Visschere P; Valerio M; van den Bergh RCN; Ost P; Tilki D; Gandaglia G; Ploussard G;
Cancer Treat Rev; 2019 Dec; 81():101927. PubMed ID: 31783313
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing hereditary cancer predisposition in men with prostate cancer.
Pritzlaff M; Tian Y; Reineke P; Stuenkel AJ; Allen K; Gutierrez S; Jackson M; Dolinsky JS; LaDuca H; Xu J; Black MH; Helfand BT
Genet Med; 2020 Sep; 22(9):1517-1523. PubMed ID: 32439974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
